Neurological syndrome in an HIV-prevention trial participant randomized to daily tenofovir disoproxil fumarate (300 mg) and emtricitabine (200 mg) in Bondo, Kenya

by Owino F, Mandala J, Ambia J, Agot K, Van Damme L
Published 2013-11-01